(Q74463869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

Primary systemic amyloidosis

11 November 2019

main subject

1 reference

R A Kyle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

232-237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

Neuropathy, M components, and amyloid

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

The natural history of peripheral neuropathy in primary systemic amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Peripheral neuropathy as an early marker of AL amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Multivariate survival analysis using Cox's regression model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Peripheral neuropathies associated with monoclonal proteins: a clinical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Primary systemic amyloidosis--a diagnostic primer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Cranial neuropathy associated with primary amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

The spectrum of peripheral neuropathy in myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Peripheral nerve changes in amyloid neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Amyloidosis with plasma cell dyscrasia. An overlooked caused of adult onset sensorimotor neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900037-0

10.1016/S0002-9343(98)00037-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552085%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference